Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Revenue (2022 - 2025)

Historic Revenue for Arcutis Biotherapeutics (ARQT) over the last 4 years, with Q3 2025 value amounting to $99.2 million.

  • Arcutis Biotherapeutics' Revenue rose 12169.37% to $99.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $317.9 million, marking a year-over-year increase of 12920.74%. This contributed to the annual value of $196.5 million for FY2024, which is 22973.53% up from last year.
  • According to the latest figures from Q3 2025, Arcutis Biotherapeutics' Revenue is $99.2 million, which was up 12169.37% from $81.5 million recorded in Q2 2025.
  • Arcutis Biotherapeutics' 5-year Revenue high stood at $99.2 million for Q3 2025, and its period low was $725000.0 during Q3 2022.
  • For the 4-year period, Arcutis Biotherapeutics' Revenue averaged around $38.3 million, with its median value being $30.9 million (2024).
  • As far as peak fluctuations go, Arcutis Biotherapeutics' Revenue surged by 403793.1% in 2023, and later skyrocketed by 3283.71% in 2025.
  • Arcutis Biotherapeutics' Revenue (Quarter) stood at $3.0 million in 2022, then surged by 356.81% to $13.5 million in 2023, then soared by 427.58% to $71.4 million in 2024, then surged by 39.04% to $99.2 million in 2025.
  • Its last three reported values are $99.2 million in Q3 2025, $81.5 million for Q2 2025, and $65.8 million during Q1 2025.